Blood Transfusion

• 

  Subject Areas on Research

  • 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. 
  • 8. Hereditary angioedema. 
  • A change in anticoagulation monitoring improves safety, reduces transfusion, and reduces costs in infants on cardiopulmonary bypass. 
  • A comparison of donor-specific and random transfusions in living-related renal transplantation and their effect on steroid withdrawal. 
  • A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. 
  • A massive transfusion protocol incorporating a higher FFP/RBC ratio is associated with decreased use of recombinant activated factor VII in trauma patients. 
  • A model to predict risk of blood transfusion after gynecologic surgery. 
  • A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. 
  • A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. 
  • A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. 
  • A randomized trial of protocol-based care for early septic shock. 
  • Acid-base status of seriously wounded combat casualties. II. Resuscitation with stored blood. 
  • Acquired peanut hypersensitivity after transfusion. 
  • Actual 10-year survival following hepatectomy for hepatocellular carcinoma. 
  • Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. 
  • Acute coronary syndromes: Blood transfusion in patients with acute MI and anaemia. 
  • Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy. 
  • Acute pulmonary decompensation due to amphotericin B in the absence of granulocyte transfusions. 
  • Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients. 
  • Adoption of transradial percutaneous coronary intervention and outcomes according to center radial volume in the Veterans Affairs Healthcare system: insights from the Veterans Affairs clinical assessment, reporting, and tracking (CART) program. 
  • Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques. 
  • Aging and reactivation of latent murine cytomegalovirus. 
  • Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. 
  • Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. 
  • Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. 
  • Alternate analysis strategies for retrospective assessment of outcomes with a male donor-only plasma policy. 
  • Amniotic fluid embolism presenting after uterine manipulation under general anesthesia: a case with a positive outcome. 
  • An assessment of medical resource utilization and hospitalization cost associated with a diagnosis of anemia in women with obstetrical bleeding in the United States. 
  • An infant girl with severe autoimmune hemolytic anemia: apparent anti-Vel specificity. 
  • Analysis of a large data set to identify predictors of blood transfusion in primary total hip and knee arthroplasty. 
  • Analysis of complication rates following perioperative transfusion in shoulder arthroplasty. 
  • Analysis of the impact of race on blood transfusion in pediatric scoliosis surgery. 
  • Anemia and blood transfusion in trauma patients admitted to the intensive care unit. 
  • Anemia and coronary artery disease: pathophysiology, prognosis, and treatment. 
  • Anemia in patients undergoing percutaneous coronary intervention: current issues and future directions. 
  • Anemia of prematurity. 
  • Anemia of prematurity. Current concepts in the issue of when to transfuse. 
  • Antibody-coated erythrocytes induce secretion of tumor necrosis factor by human monocytes: a mechanism for the production of fever by incompatible transfusions. 
  • Antifibrinolytic therapy in the management of the Kasabach Merritt syndrome. 
  • Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. 
  • Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial. 
  • Aprotinin versus tranexamic acid: the controversy continues. 
  • Aspirin and bleeding after coronary artery bypass grafting. 
  • Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malaria. 
  • Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. 
  • Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. 
  • Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. 
  • Association of the 98T ELAM-1 polymorphism with increased bleeding after cardiac surgery. 
  • Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses. 
  • Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. 
  • Bleeding and management of coagulopathy. 
  • Bleeding as a predictor of mortality risk. 
  • Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. 
  • Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management. 
  • Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. 
  • Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. 
  • Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patients. 
  • Blood Products in the Management of Abnormal Placentation. 
  • Blood Transfusion and the Risk of Acute Kidney Injury Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. 
  • Blood conservation in cardiac surgery. Preliminary results with an institutional commitment. 
  • Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis. 
  • Blood transfusion during acute myocardial infarction: association with mortality and variability across hospitals. 
  • Blood transfusion in patients with acute coronary syndrome. 
  • Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients. 
  • Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. 
  • Bloodless Orthotopic Heart Transplantation in a Jehovah's Witness. 
  • CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation. 
  • CE: A Review of Current Practice in Transfusion Therapy. 
  • Cancer- and chemotherapy-induced anemia. 
  • Cancer- and chemotherapy-induced anemia. 
  • Cancer- and treatment-related anemia. 
  • Captopril-enhanced binding of PlA1 (HPA-1a) antibodies in posttransfusion purpura. 
  • Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection. 
  • Cell Saver for Adult Spinal Deformity Surgery Reduces Cost. 
  • Clinical implications of the loss of vasoactive nitric oxide during red blood cell storage. 
  • Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis. 
  • Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study. 
  • Clinical use of oral contraceptives administered vaginally: a case report. 
  • Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. 
  • Coagulation changes in elective surgery and trauma. 
  • Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies. 
  • Combined deficiency of factors II, VII, IX, and X (Borgschulte-Grigsby deficiency) in pregnancy. 
  • Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals. 
  • Comparative effectiveness of treatment strategies for severe splenic trauma in the pediatric population. 
  • Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. 
  • Comparison of bivalirudin versus heparin(s) during percutaneous coronary interventions in patients receiving prasugrel: a propensity-matched study. 
  • Comparison of red cell transfusion and polyethylene glycol-modified adenosine deaminase therapy in an adenosine deaminase-deficient child: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool. 
  • Comparison of the Trends in Risk Factors and Management of Severe Postpartum Hemorrhage Years 2000-2004 Versus 2005-2008 
  • Comparison of the costs and morbidity of percutaneous and open flank procedures. 
  • Complications of hysterectomy in women with von Willebrand disease. 
  • Complications of implantable venous access devices in patients with sickle cell disease. 
  • Concepts of blood transfusion in adults. 
  • Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. 
  • Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. 
  • Cost analysis of abdominal, laparoscopic, and robotic-assisted myomectomies. 
  • Cost-minimization analysis of robotic-assisted, laparoscopic, and abdominal sacrocolpopexy. 
  • Costs and outcomes after cardiac surgery in patients refusing transfusion compared with those who do not: a case-matched study. 
  • Cryotherapy temperature differences after total knee arthroplasty: a prospective randomized trial. 
  • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. 
  • Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. 
  • Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report. 
  • Design of the silent cerebral infarct transfusion (SIT) trial. 
  • Detection of platelet isoantibodies by (3H)serotonin platelet release and its clinical application to the problem of platelet matching. 
  • Development and validation of a generalizable model for predicting major transfusion during spine fusion surgery. 
  • Diabetes and early postoperative outcomes following lumbar fusion. 
  • Disseminated intravascular coagulation and renal failure: Production in the monkey with autologous red blood cell stroma. 
  • Do white cells in stored blood components reduce the likelihood of posttransfusion bacterial sepsis? 
  • Does body mass index impact the outcomes of tubeless percutaneous nephrolithotomy? 
  • Dual Diagnosis and Total Hip Arthroplasty. 
  • Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia. 
  • Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. 
  • Economic assessment of thrombocytopenia: CATCH Registry. 
  • Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial. 
  • Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery. 
  • Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial. 
  • Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma. 
  • Effectiveness of preoperative autologous blood donation for protection against allogeneic blood exposure in adult spinal deformity surgeries: a propensity-matched cohort analysis. 
  • Effects of extreme hemodilution during cardiac surgery on cognitive function in the elderly. 
  • Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. 
  • Effects of race and clinical factors on short-term outcomes of abdominal myomectomy. 
  • Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. 
  • Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial. 
  • Elective cholecystectomy in children with sickle hemoglobinopathies. Successful outcome using a preoperative transfusion regimen. 
  • Emergency subtotal colectomy in a Jehovah's Witness with massive lower gastrointestinal bleeding: challenges encountered and lessons learned. 
  • Encouraging single-unit transfusions: a superior patient blood management strategy? 
  • Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. 
  • Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty. 
  • Equilibration of hemoglobin concentration after transfusion in medical inpatients not actively bleeding. 
  • Ethical aspects of banking placental blood for transplantation. 
  • Evaluation and management of bleeding during cardiac surgery. 
  • Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registry. 
  • Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection. 
  • Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion. 
  • Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. 
  • Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study Group. 
  • Fertility challenges for women with sickle cell disease. 
  • Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy. 
  • Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. 
  • Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. 
  • Guidelines for perioperative blood transfusion and conservation in cardiac surgery: lessons and challenges. 
  • Hand-Assisted Laparoscopic Colectomy Improves Perioperative Outcomes Without Increasing Operative Time Compared to the Open Approach: a National Analysis of 8791 Patients. 
  • Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy. 
  • Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study. 
  • Hematologic and surgical management of the dental patient with plasminogen activator deficiency. 
  • Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. 
  • Hemolytic transfusion reactions caused by failure of commercial antiglobulin reagents to detect complement. 
  • Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. 
  • Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. 
  • Hepatitis C infection in children with hemophilia A and B. 
  • Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group. 
  • Hereditary angioedema: the clinical syndrome and its management. 
  • Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. 
  • High prevalence of malaria parasitemia and anemia among hospitalized children in Rakai, Uganda. 
  • High-dose intravenous immunoglobulin for severe platelet alloimmunization. 
  • Hip arthroplasty after extracapsular hip fracture: a matched pair cohort analysis. 
  • How I use fibrinogen replacement therapy in acquired bleeding. 
  • How do North Carolina prenatal care providers counsel and test pregnant women for HIV? Survey measures knowledge of HIV testing benefits. 
  • How do we develop and implement a preoperative anemia clinic designed to improve perioperative outcomes and reduce cost? 
  • Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. 
  • Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. 
  • Hydroxyurea: an alternative to transfusion therapy for stroke in sickle cell anemia. 
  • IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. 
  • Immune hemolytic transfusion reactions in monkeys: activation of the kallikrein system. 
  • Immunoreconstitution. 
  • Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. 
  • Impact of hydroxyurea on perioperative management and outcomes in children with sickle cell anemia. 
  • Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. 
  • Impact of preoperative neurological status on perioperative morbidity associated with anterior and posterior cervical fusion. 
  • Impaired adenosine-5'-triphosphate release from red blood cells promotes their adhesion to endothelial cells: a mechanism of hypoxemia after transfusion. 
  • Implications of bleeding and blood transfusion in percutaneous coronary intervention. 
  • In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in-line WBC-reduction filter. 
  • Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. 
  • International normalized ratio. 
  • International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes. 
  • Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation. 
  • Intraoperative autotransfusion in aortic surgery. 
  • Intraoperative fluid management during orthotopic liver transplantation. 
  • Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations. 
  • Invited commentary. 
  • Invited commentary. 
  • Iron deficiency anemia and increased urinary norepinephrine excretion. 
  • Is old blood bad blood? 
  • Is there a transfusion effect in combined pancreas-kidney transplantation? 
  • Isoantibody specificity in post-transfusion purpura. 
  • Jehovah's Witnesses and cardiac surgery: a single institution's experience. 
  • Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study. 
  • Laparoscopic cholecystectomy in young patients with sickle hemoglobinopathies. 
  • Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. 
  • Leukocyte phenotypic changes in an in vitro model of ABO hemolytic transfusion reaction. 
  • Leukocyte-reduced blood transfusions: perioperative indications, adverse effects, and cost analysis. 
  • Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. 
  • Liver abscess following exchange transfusion for erythroblastosis fetalis. 
  • Long-term management of splenic sequestration in children with sickle cell disease. 
  • Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. 
  • Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. 
  • Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. 
  • Maintenance of therapeutic plasma aprotinin levels during prolonged cardiopulmonary bypass using a large-dose regimen. 
  • Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation. 
  • Management of abdominal aortic graft complications. 
  • Management of complex pediatric and adolescent spinal deformity. 
  • Management of febrile neutropenia in a patient with acute leukemia. 
  • Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. 
  • Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. 
  • Management of surgical hemostasis: systemic agents. 
  • Managing clotting: a North American perspective. 
  • Many, but not all, outcome studies support exclusion of female plasma from the blood supply. 
  • Marrow transplantation for aplastic anemia. 
  • Marrow transplantation for thalassaemia. 
  • Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment? 
  • Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. 
  • Massive transfusion exceeding 50 units of blood products in trauma patients. 
  • Maternal outcomes associated with planned vaginal versus planned primary cesarean delivery. 
  • Medical and infectious complications associated with pyelonephritis among pregnant women at delivery. 
  • Medical, ethical and legal issues regarding thrombolytic therapy in the Jehovah's Witness. 
  • Modifiable Risk Factors in Necrotizing Enterocolitis. 
  • Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification. 
  • Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. 
  • Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies. 
  • Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants. 
  • Neonatal alloimmune thrombocytopenic purpura. 
  • Obstetric hemorrhage. 
  • Oral manifestations and dental management of patients with hereditary angioedema. 
  • Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial. 
  • Outcomes of Conversion Total Hip Arthroplasty From Free Vascularized Fibular Grafting. 
  • Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation. 
  • Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony. 
  • Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial. 
  • Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. 
  • Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference. 
  • Patient blood management during cardiac surgery: do we have enough evidence for clinical practice? 
  • Patients' attitudes regarding out-of-hospital blood transfusion. 
  • Percent body fat more associated with perioperative risks after total joint arthroplasty than body mass index. 
  • Perflubron emulsion (AF0144) augments harvesting of autologous blood: a phase II study in cardiac surgery. 
  • Perioperative Optimization of Geriatric Lower Extremity Bypass in the Era of Increased Performance Accountability. 
  • Perioperative Outcomes and Management in Pediatric Complex Cranial Vault Reconstruction: A Multicenter Study from the Pediatric Craniofacial Collaborative Group. 
  • Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. 
  • Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. 
  • Perioperative blood transfusion in patients with colon carcinoma. 
  • Perioperative coagulation management in the intensive care unit. 
  • Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. 
  • Phenotype and function of T cells propagated from donor-specific blood transfusion enhanced and autologous blood transfused rejecting rat renal allografts. 
  • Photoinactivation of lymphohemopoietic cells: studies in transfusion medicine and bone marrow transplantation. 
  • Physiologic correlates of intraoperative blood transfusion among patients undergoing major gastrointestinal operations. 
  • Plasma therapy in immunodeficiency diseases. 
  • Plasma therapy in immunodeficiency diseases. 
  • Plasma volume and sulfate spaces in acute combat casualties. 
  • Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. 
  • Platelet inhibitors and bleeding in cardiac surgical patients. 
  • Postpartum hemorrhage management in 2012: predicting the future. 
  • Practice pattern variability for myocardial revascularization: impact on resource use across 24 centers. 
  • Precatheterization Use of P2Y12 Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry®. 
  • Predicting peripartum blood transfusion in women undergoing cesarean delivery: A risk prediction model. 
  • Prednisone-responsive aplastic anemia associated with T-lymphocyte proliferation. 
  • Pregnancy associated with paroxysmal nocturnal hemoglobinuria. 
  • Preoperative Hemoglobin Predicts Postoperative Transfusion Despite Antifibrinolytics During Total Knee Arthroplasty. 
  • Preoperative coagulation testing on a gynecologic oncology service. 
  • Preoperative transarterial embolization of spinal column neoplasms. 
  • Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity. 
  • Prevalence of HTLV-I-associated T-cell lymphoma. 
  • Prevention and diagnosis of delayed haemolytic transfusion reactions. 
  • Prevention and treatment of coagulopathy in patients receiving massive transfusions. 
  • Priapism in association with sickle hemoglobinopathies in children. 
  • Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. 
  • Principles and problems of transfusion in sickle cell disease. 
  • Pro: low central venous pressure during liver transplantation--not too low. 
  • Prophylactic correction of the international normalized ratio in neurosurgery: a brief review of a brief literature. 
  • Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. 
  • Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. 
  • Protocol adherence when managing massive bleeding following complex cardiac surgery: a study design pilot. 
  • RBC transfusions in paroxysmal nocturnal hemoglobinuria. 
  • Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group. 
  • Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. 
  • Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. 
  • Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study. 
  • Red cell antigens as functional molecules and obstacles to transfusion. 
  • Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. 
  • Red cell transfusion in the newborn. Indications and unique blood banking needs. 
  • Reduction in blood transfusion in a cohort of infants having cardiac surgery with cardiopulmonary bypass after instituting a goal-directed transfusion policy. 
  • Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. 
  • Reductions in blood loss with a bipolar sealer in total hip arthroplasty. 
  • Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management. 
  • Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. 
  • Renal allograft cell infiltrates associated with irreversible rejection. 
  • Response to Dr Sandar et al. 
  • Response. 
  • Restoration of intracellular ATP production in banked red blood cells improves inducible ATP export and suppresses RBC-endothelial adhesion. 
  • Results and morbidity of percutaneous nephrolithotripsy. 
  • Retroperitoneal and rectus sheath hematomas. 
  • Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. 
  • Rotational thromboelastometry-guided blood product management in major spine surgery. 
  • S-nitrosylation therapy to improve oxygen delivery of banked blood. 
  • Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. 
  • Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein IIb/IIIa in patients undergoing elective coronary angioplasty. 
  • Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery. 
  • Safety of aprotinin in heparinized and nonheparinized patients. 
  • Serological evidence of cross infection in a dialysis unit hepatitis-B epidemic. 
  • Serum enzyme alterations after extensive surgical procedures. 
  • Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting. 
  • Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion. 
  • Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. 
  • Sex differences in utilization and outcomes of catheter-directed thrombolysis in patients with proximal lower extremity deep venous thrombosis - Insights from the Nationwide Inpatient Sample. 
  • Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation. 
  • Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials. 
  • Similarities in long-term alloreactive T cell lines propagated from transfusion-enhanced and control-rejecting rat renal allografts. 
  • Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry). 
  • Spinal fusion for pediatric neuromuscular scoliosis: national trends, complications, and in-hospital outcomes. 
  • Storage age of transfused platelets and outcomes after cardiac surgery. 
  • Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation. 
  • Supportive care of the marrow transplant recipient: the Seattle Experience. 
  • Systemic loxoscelism in a nonendemic area: a diagnostic challenge for the unsuspecting physician. 
  • Technology: Is There Sufficient Evidence to Change Practice in Point-of-Care Management of Coagulopathy? 
  • The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. 
  • The anemia of prematurity and the decision when to transfuse. 
  • The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses. 
  • The better colectomy project: association of evidence-based best-practice adherence rates to outcomes in colorectal surgery. 
  • The cellular basis of traumatic bleeding. 
  • The clinical manifestations of cerebral malaria among Nigerian children with the sickle cell trait. 
  • The clinical significance of blood transfusion at the time of radical hysterectomy. 
  • The coagulopathy of trauma versus disseminated intravascular coagulation. 
  • The economic burden of anemia in cancer patients receiving chemotherapy. 
  • The effect of intentional hemodilution on P50. 
  • The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells. 
  • The effects of donor-specific blood transfusion enhancement of rat renal allografts on host NK cell responses. 
  • The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation. 
  • The implementation and efficacy of the Northwestern High Risk Spine Protocol. 
  • The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. 
  • The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival. 
  • The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. 
  • The relationship of transfusion and presensitization with graft and patient survival. 
  • The role of RT1.a major histocompatibility antigens in prolonging the survival of hepatic allografts in the rat. 
  • The role of aprotinin in a blood-conservation program. 
  • The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat. 
  • The selection and evaluation of new chelating agents for the treatment of iron overload. 
  • The transfusion problem: role of aberrant S-nitrosylation. 
  • The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. 
  • Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. 
  • Total blood transfusion and mortality after orthotopic liver transplantation. 
  • Total shoulder arthroplasty in patients with HIV infection: complications, comorbidities, and trends. 
  • Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. 
  • Transfusion and hemostasis in cardiac surgery. 
  • Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation. 
  • Transfusion in critical care - a UK regional audit of current practice. 
  • Transfusion management in sickle cell disease. 
  • Transfusion medicine: the problem of HIV infection. 
  • Transfusion nomogram: an application of physiology to clinical decisions regarding the use of blood. 
  • Transfusion of sickle cells may be a therapeutic option for patients suffering metastatic disease. 
  • Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. 
  • Transfusion practices for patients with sickle cell disease at a major academic medical center. 
  • Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease. 
  • Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model. 
  • Transplantation for polycystic kidney disease. 
  • Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). 
  • Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. 
  • Two cases of transfusion-associated graft-vs-host disease after open heart surgery. 
  • Unique immunologic problems in human bone marrow transplant recipients. 
  • Urgent colonoscopy for evaluation and management of acute lower gastrointestinal hemorrhage: a randomized controlled trial. 
  • Use of Adjuncts Reduces Cardiopulmonary Bypass Time During Minimally Invasive Aortic Valve Replacement. 
  • Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest. 
  • Utilizing a Novel Mobile Health "Selfie" Application to Improve Compliance to Iron Chelation in Pediatric Patients Receiving Chronic Transfusions. 
  • Variation in Warfarin Use at Hospital Discharge After Isolated Bioprosthetic Mitral Valve Replacement: An Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Vincristine therapy for severe platelet alloimmunization. 
  • Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade. 
  • Visual loss after spine surgery: a population-based study. 
  • Warfarin therapy does not increase bleeding in patients undergoing heart transplantation. 
  • Weight gain: a response to transfusion in selected preterm infants. 
  • What Is the PROPPR Transfusion Strategy in Trauma Resuscitation? 
  • What Should Define Preoperative Anemia in Primary THA? 
  • What is blood and what is not? Caring for the Jehovah's Witness patient undergoing cardiac surgery. 
  • When Should Complete Blood Count Tests Be Performed in Primary Total Hip Arthroplasty Patients? 
  • When clinical medicine collides with religion. 
  • Why do secondary cadaver renal transplants succeed? Results of the South-Eastern Organ Procurement Foundation prospective study, 1977-1982. 
  • Will submandibular TCD prevent stroke in children with sickle cell anemia? 
• 

  Keywords of People

  • Abbruzzese, James, D. C. I. Professor of Medical Oncology, Medicine, Medical Oncology
  • Attarian, David Edward, Professor of Orthopaedic Surgery, Orthopaedics
  • Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Hoffman, Maureane Richardson, Professor of Pathology, Immunology
  • Levy, Jerrold Henry, Professor of Anesthesiology, Anesthesiology, Cardiothoracic
  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Preminger, Glenn Michael, James F. Glenn, M.D. Professor of Urology, Surgery
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic
  • Zennadi, Rahima, Associate Professor in Medicine, Pathology